ArticleFrontiers in oncology2025
Temporal trends of cervical cancer demographics: a CDC WONDER database study.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Recent national trends in pelvic and paraaortic lymphadenectomy in gynecologic oncology fellowship training programs: ACGME data from 2019-2025.Gynecologic oncology reports · 2026Article
- National Trends in Radical Hysterectomy at Gynecologic Oncology Fellowship Training Programs.O&G open · 2026Article
- Article
- Trends in renal failure-related mortality among U.S. multiple myeloma patients aged ≥ 45 years, 1999-2023: analysis of CDC data.Scientific reports · 2026Article
- Declining trends but persistent disparities in cervical cancer mortality in the United States, 1999-2023.Frontiers in public health · 2026Article
- Mortality trends and influencing factors of mental disorders among urban and rural residents in China between 2009 and 2021: a longitudinal study with projections to 2030.Frontiers in public health · 2026Article
- Trends and Disparities in Mortality from Malignant Parotid Gland Tumors in the United States, 1999-2023: A Population-Based Analysis.Cancer informatics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Despite advancements in cervical cancer screening and HPV vaccines, demographic disparities perpetuate the burden of cervical cancer. The aim of this study is to utilize the most up-to-date CDC WONDER data of cervical cancer mortality to provide a comprehensive temporal analysis of demographic variables and account for patients missed in other database studies. In doing so, temporal trends found in this study may be used to guide future efforts and studies to understand nuanced barriers to cervical cancer screening and prevention. Methods: With CDC WONDER Data, cervical cancer-related mortality was assessed in the U.S. from 1999 to 2023. Using age-adjusted mortality rates (AAMR), temporal trends were analyzed using the Joinpoint Regression Program for women 25 years and older across race, census regions, urban/rural residence, and states. Annual percentage change (APC) and average annual percentage change (AAPC) were calculated with 95% confidence intervals. Results: Cervical cancer-related mortality declined over the study period with an AAPC of -1.043*. Between 2015 and 2023, there was a concerning positive change in AAMR [APC of 0.1272 (95% CI -0.3393 to 1.7502)], though not statistically significant. Black or African American patients experienced the highest AAMR across races but maintained a decrease in mortality rate over the study period [AAPC of -2.670* (95% CI -2.931 to -2.356)]. Region and race analysis demonstrated Black or African American patients in the Northeast held the largest decline in AAMR [AAPC of -3.218* (95% CI -3.708 to -2.390)], while Hispanic or Latino and Black or African American patients in the South closely followed AAPC of -1.347* (-1.898 to -0.824) and -2.656* (95% CI -2.939 to -2.350), respectively]. Rural areas (NonCore and Micropolitan) and the Southern region displayed a concerning positive trend after 2009 and 2010, though not statistically significant [APC values of 0.772 (95% CI -0.328 to 4.888), 0.986 (95% CI -0.252 to 4.887), and 0.286 (95% CI -0.061 to 0.772), respectively]. Conclusion: These findings underscore the need for targeted interventions with consideration of regional and racial temporal disparities in cervical cancer-related mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.